Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles: a mul- ticenter, randomized, placebo-controlled clinical trial. Circulation. 2005;112:2411 6. S3.14.1-11. Giardini A, Lovato L, Donti A, et al. A pilot study on the effects of carvedilol on right ventricular remodelling and exercise tol- erance in patients with systemic right ventricle. Int J Cardiol. 2007;114:241 6. S3.14.1-12. Doughan ARK, McConnell ME, Book WM. Effect of beta block- ers (carvedilol or metoprolol XL) in patients with transposition of great arteries and dysfunction of the systemic right ventricle. Am J Cardiol. 2007;99:704 6. S3.14.1-13. Therrien J, Provost Y, Harrison J, et al. Effect of angiotensin re- ceptor blockade on systemic right ventricular function and size: a small, randomized, placebo-controlled study. Int J Cardiol. 2008;129:187 92. S3.14.1-14. Bouallal R, Godart F, Francart C, et al. Interest of -blockers in patients with right ventricular systemic dysfunction. Cardiol Young. 2010;20:615 9. S3.14.1-15. Tutarel O, Meyer GP, Bertram H, et al. Safety and efficiency of chronic ACE inhibition in symptomatic heart failure patients with a systemic right ventricle. Int J Cardiol. 2012;154:14 6. S3.14.1-16. van der Bom T, Winter MM, Bouma BJ, et al. Effect of valsar- tan on systemic right ventricular function: a double-blind, ran- domized, placebo-controlled pilot trial. Circulation. 2013;127: 322 30. S3.14.1-17. Dos L, Pujadas S, Estruch M, et al. Eplerenone in systemic right ventricle: double blind randomized clinical trial. The EVEDES Study. Int J Cardiol. 2013;168:5167 73. S3.14.1-18. Kouatli AA, Garcia JA, Zellers TM, et al. Enalapril does not enhance exercise capacity in patients after Fontan procedure. Circulation. 1997;96:1507 12. S3.14.1-19. Giardini A, Balducci A, Specchia S, et al. Effect of sildenafil on hae- modynamic response to exercise and exercise capacity in Fontan patients. Eur Heart J. 2008;29:1681 7. S3.14.1-20. Goldberg DJ, French B, McBride MG, et al. 